Unexpectedly, Ruixing's surgery robot hasn't hit the market, yet it has already garnered so many orders. The biggest issue now is that the approvals in Europe and America are still in process, and the buyers, even needing it for research as experimental equipment, want to purchase it immediately.
Huang Jiacai did the math; current orders have exceeded three hundred units. To put that in perspective, a leading brand of surgery robots globally has only sold over seven hundred units since its launch, while Ruixing's surgery robot, upon launch, has sold over three hundred, starting off with half the cumulative global sales of others.
This is despite Ruixing Company halting order acceptance due to temporary production capacity issues, as they need to ensure the quality delivery of existing orders. Huang Jiacai is determined to build the world's top surgery robot brand.
